内镜活检黏膜正常后结直肠癌的长期发病率与死亡率:一项瑞典匹配队列研究
这项瑞典匹配队列研究纳入88,798例首次结直肠活检黏膜正常者(年龄≥50岁)和424,150名匹配对照,随访至44年。正常活检组20年结直肠癌发病率为3.03%、死亡率为0.89%,均低于对照组的4.53%和1.54%,多变量风险比分别为0.62和0.56。作者认为正常结肠镜检查后的筛查间隔可能长于常推荐的10年。
要点
- 首次结直肠活检黏膜正常者20年结直肠癌发病率为3.03%,对照组为4.53%。
- 正常活检组20年结直肠癌死亡率为0.89%,对照组为1.54%。
- 作者认为正常结肠镜检查后的筛查间隔可能长于常推荐的10年。
核心结论
- 正常结直肠活检与检查后至少20年较低的结直肠癌发病率和死亡率相关。
- 作者认为研究结果证实了既往数据,并提示正常结肠镜检查后的筛查间隔可能长于常推荐的10年。
- 作者提出可能到了讨论修订国际指南的时候。
研究设计与样本
- 匹配队列研究,使用瑞典全国胃肠流行病学强化组织病理学报告(ESPRESSO)1965-2016年前瞻性收集的数据。
- 纳入88,798例首次结直肠活检黏膜正常且年龄≥50岁的个体,以及424,150名来自一般人群的匹配对照。
- 采用Cox比例风险回归估计结直肠癌发病率和死亡的多变量风险比及95%置信区间,随访至44年。
主要发现
- 正常活检组与对照组20年结直肠癌发病率分别为3.03%和4.53%,20年结直肠癌死亡率分别为0.89%和1.54%。
- 正常活检组相比对照组结直肠癌发病的多变量风险比为0.62(95%CI=0.58-0.66,P<0.001),结直肠癌死亡的多变量风险比为0.56(95%CI=0.49-0.64,P<0.001)。
- 按活检后时间间隔评估,整个随访期间均观察到较低的结直肠癌发病率和死亡率。
- 该关联在近端结肠癌中似乎弱于直肠癌和远端结肠癌。
临床怎么用
- 作者认为正常结肠镜检查后的筛查间隔可能长于常推荐的10年。
- 作者提出可能到了讨论修订国际指南的时候。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Endoscopic screening reduces colorectal cancer (CRC) incidence and mortality. Individuals with a negative result are recommended to undergo rescreening within a 10-year interval, but evidence supporting this advice is limited. METHODS: We performed a matched cohort study using prospectively collected data from 88,798 individuals in Sweden with normal mucosa at the first colorectal biopsy (aged ≥50 years) in the nationwide gastrointestinal epidemiology strengthened by histopathology reports (ESPRESSO) (1965-2016) and 424,150 matched reference individuals from the general population. Cox proportional hazards regression estimated multivariable hazard ratios and 95% confidence intervals (CIs) of CRC incidence and mortality of incident CRCs up to 44 years of follow-up. RESULTS: In the normal biopsy and reference groups, respectively, the 20-year incidences of CRC were 3.03% and 4.53% and the 20-year mortalities of incident CRC were 0.89% and 1.54%. The multivariable hazard ratio comparing the normal biopsy and reference groups was 0.62 for CRC incidence (95% CI = 0.58-0.66, P < 0.001) and 0.56 for mortality of incident CRC (95% CI = 0.49-0.64, P < 0.001). When assessed by time interval after biopsy, lower CRC incidence and mortality were observed throughout the follow-up. The association seemed weaker for proximal colon cancer than for rectal and distal colon cancer. DISCUSSION: A normal colorectal biopsy was associated with lower CRC incidence and mortality for at least 20 years after the examination. Our findings confirm previous data and suggest that the screening intervals after a normal colonoscopy could be longer than the commonly recommended 10 years. It may be time to open the discussion for a revision of the international guidelines.
引用
- Song M, Emilsson L, Hultcrantz R, et al. Long-Term Incidence and Mortality of Colorectal Cancer After Endoscopic Biopsy With Normal Mucosa: A Swedish-Matched Cohort Study. Am J Gastroenterol. 2021. PMID: 33105194. doi:10.14309/ajg.0000000000001018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。